Filtered Listing Testing
Download the fall 2014 issue of our macular degeneration newsletter to learn more about cutting-edge AMD research showcased at the XVI International Symposium on Retinal Degeneration, ways to help prevent AMD, and much more.
Researchers from Yale School of Medicine have discovered a promising new drug compound that reverses some Alzheimer’s effects on memory in mice. They found that a protein drug compound, known as TC-2153, blocks the Alzheimer’s disease linked effects of another protein called striatal-enriched tyrosine phosphatase (STEP). At high levels, STEP prevents synaptic strengthening in the brain—something vital to memory function.
Recently, the BrightFocus Foundation awarded an Alzheimer’s Disease Research Fellowship to Soong Ho Kim, PhD, at Mount Sinai Hospital in New York City, to study whether a new drug could directly attack symptoms of Alzheimer's disease, but also work to address the disease process. A new study in Molecular Psychiatry now provides evidence that this line of research may be progressing."
Download the fall 2013 issue of our Alzheimer’s disease newsletter to learn about key areas of study in Alzheimer’s research, a link between anemia and increased dementia risk, and much more.
Download the spring 2014 issue of our Alzheimer’s disease newsletter to learn about 14 new genes linked to early-onset Alzheimer’s disease, a potential link between concussions and Alzheimer’s, and much more.
Download the summer 2014 issue of our Alzheimer's disease newsletter and learn about a blood test with a 90% success rate for predicting Alzheimer's, a link between cardiovascular and brain health, and much more.